Navigation Links
GeneLink Announces HelixLife Private Label Distribution Agreement
Date:9/24/2010

ingredients, and are shipped directly from production to customer, not warehouse-stored.  For more information, go to www.helixlife.com.

About GeneLink BioSciences, Inc.  

GeneLink is a genomics, biotechnology, and wellness company engaged in genetic test development, product development, and manufacturing of personalized wellness products.  GeneLink's patented and proprietary technologies include genetic assessments focused on the delivery of personally customized and manufactured nutritional supplements and skin care products for health, beauty and wellness applications. For additional information, please visit www.genelinkbio.com.

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.



'/>"/>
SOURCE GeneLink BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GeneLink Reports First Quarter Gains
2. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
3. SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
4. PAREXEL Announces Date of First Quarter Fiscal Year 2011 Earnings Release and Conference Call
5. Advanced Targeting Systems, Inc. Announces $3 Million Award from National Cancer Institute
6. Genesis Biopharma Announces $700K Private Financing
7. S*BIO Announces US$5 Million Investment by Mitsui Ventures
8. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
9. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
10. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
11. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Calif. , July 25, 2014 Amgen ... of Directors today declared a $0.61 per share dividend ... be paid on Sept. 5, 2014, to all stockholders ... Aug. 14, 2014.  About Amgen Amgen ... patients suffering from serious illnesses by discovering, developing, manufacturing ...
(Date:7/25/2014)... According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 ... at USD 161,056.5 million in 2014 and is expected ... to 2020, to reach an estimated value of USD ... is witnessing a significant growth due to the increasing ...
(Date:7/25/2014)... 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... today announced financial results for the period ended June ... , Reported cash and cash equivalents totaling $37.4 ... December 31, 2013.  , Reported a net loss ...
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... May 11 /PRNewswire-Asia-FirstCall/ -- China,Baicaotang Medicine Ltd. (OTC Bulletin Board: ... in the, Guangxi Province of China announced today that ... the,Company. , , , ... Mr. Tang Hui Tian , Chairman and CEO of CBT, ...
... of more affordable drugs, vaccines and diagnostics that would ... from a growing number of collaborations between biotech firms ... published Mon. May 10 in the UK journal ... countries, together with colleagues at Canada,s McLaughlin-Rotman Centre for ...
... May 10 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ("China Sky ... pharmaceutical company producing over-the-counter drugs in, the People,s Republic of China , ... of $10.1 million for the first quarter,ended March 31, ... ...
Cached Biology Technology:Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd. 2Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd. 3Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 2Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 3Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 4Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 5Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 6Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 7China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call 2China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call 3China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call 4China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call 5China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call 6
(Date:7/25/2014)... 24, 2014)The link between autism and disrupted brain ... of the disease, and is largely unknown. However, ... Research Initiative (SFARI), George Washington University (GW) researcher ... truly integrative and in-depth answers to these key ... , LaMantia, professor of pharmacology and physiology at ...
(Date:7/25/2014)... Birla, associate professor of biomedical engineering at the ... on tissue engineering and artificial organ development., "Introduction ... comprehensive guide to entering into the field of ... professor of biomedical engineering at UH, served as ... that while there are other published books on ...
(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2University of Houston researcher publishes textbook on tissue engineering 2
... Capabilities for Use in a Wide,Range ... Vision Applications, VILNIUS, Lithuania, Sept. ... provider of high-precision biometric,and object identification ... 2.0 SDK universal object recognition technology ...
... always good to respond maximally when pathogens or disease ... balance immediate and future costs? This is the question ... Tony Williams asked when they examined how a simple ... life-span of individual zebra finches ( Taeniopygia guttata ), ...
... of stripy legs in a camera trap photo snapped in ... from the Wildlife Conservation Society. The legs belong to an ... Republic of Congo,s Virunga National Park, despite over a decade ... the first time this species has been captured on film ...
Cached Biology News:Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology 2Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology 3Individuals vary their immune response according to age, sex and the costs 2Photo reveals rare okapi survived poaching onslaught 2
... Imaging System, Professional Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... for both proteomic and general life science ... enabling the use of all dyes in ...
... Corning single use spatulas have been ... samples. They are for those interested in ... reusable spatulas. Each spatula is individually packaged, ... CLS number is a new product number, ...
... digital valve, just 8 mm in width. ... in a single glass-reinforced, PBT (Polybutylene Terephthalate) molded ... width. , Meets a range of pressure requirements ... Satisfies a 0.016 sccm leakage specification (0.2 sccm ...
... FilterMate is a compact, versatile system that ... 96- or 24-well microplates into a solid ... liquid scintillation and gamma counter. The FilterMate ... for applications such as cell proliferation, receptor ...
Biology Products: